glp 1 sglt2

glp 1 sglt2 Use of GLP-1 Receptor Agonists and Inhibitors Among Patients with Type Diabetes: A Nationwide Register-Based Cohort Study SGLT2 vs GLP-1 for CKD:

Name: glp 1 sglt2 Use of GLP-1 Receptor Agonists and Inhibitors Among Patients with Type Diabetes: A Nationwide Register-Based Cohort Study SGLT2 vs GLP-1 for CKD:
Brand: 2m-capital.com
SKU: 41313347609
Price: 27.81 USD
Availability: InStock
Rating: 4.0117 (23 reviews)

SKU: 41313347609

4.0

EUR27.81 EUR77.81

Pay in 4 interest-free payments of $6.95 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 10 - Nov 15

Description

Practice Pearls: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral drugs for type 2 diabetes that inhibit the breakdown of glucagon-like peptide-1 (GLP-1) and increase the release of insulin in response to a meal

The Egger test for these outcomes indicated some asymmetry for CV death only (P = 0.10)

BohneLJJansenHJDoreyTWDanielIMJamiesonKLBelkeDDet alGlucagon-like peptide-1 protects against atrial fibrillation and atrial remodeling in type 2 diabetic mice